Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI World Health Care |
| Investment focus | Equity, World, Health Care |
| Fund size | GBP 740 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Synthetic (Unfunded swap) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 14.01% |
| Inception/ Listing Date | 19 August 2010 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | SOCIETE GENERALE LUXEMBOURG |
| Investment Advisor | |
| Custodian Bank | Societe Generale Luxembourg |
| Revision Company | PWC |
| Fiscal Year End | 31 December |
| Swiss representative | Société Générale, Paris, Zweigniederlassung Zürich |
| Swiss paying agent | Société Générale, Paris, Zweigniederlassung Zürich |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | Société Générale |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Eli Lilly & Co. | 11.65% |
| Johnson & Johnson | 7.63% |
| AbbVie, Inc. | 5.53% |
| UnitedHealth Group Inc | 4.62% |
| Merck & Co., Inc. | 3.87% |
| Roche Holding AG | 3.75% |
| Novartis AG | 3.47% |
| AstraZeneca PLC | 3.09% |
| Thermo Fisher Scientific, Inc. | 2.55% |
| Amgen, Inc. | 2.52% |
| United States | 71.37% |
| Switzerland | 9.55% |
| United Kingdom | 5.07% |
| Japan | 3.22% |
| Other | 10.79% |
| Healthcare | 97.50% |
| Consumer Non-Cyclicals | 1.65% |
| Consumer Cyclicals | 0.69% |
| Business Services | 0.11% |
| Finance | 0.06% |
| Other | 0.00% |
| YTD | +8.33% |
| 1 month | +4.79% |
| 3 months | +15.04% |
| 6 months | +4.92% |
| 1 year | +20.50% |
| 3 years | +20.15% |
| 5 years | +26.65% |
| Since inception (MAX) | +541.29% |
| 2025 | +6.51% |
| 2024 | +2.60% |
| 2023 | -2.14% |
| 2022 | +6.05% |
| Volatility 1 year | 14.01% |
| Volatility 3 years | 12.90% |
| Volatility 5 years | 13.67% |
| Return per risk 1 year | 1.46 |
| Return per risk 3 years | 0.49 |
| Return per risk 5 years | 0.35 |
| Maximum drawdown 1 year | -11.13% |
| Maximum drawdown 3 years | -18.79% |
| Maximum drawdown 5 years | -18.79% |
| Maximum drawdown since inception | -18.79% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | LYPE | - - | - - | - |
| Stuttgart Stock Exchange | EUR | LYPE | - - | - - | - |
| Borsa Italiana | EUR | HLTW | Société Générale | ||
| Borsa Italiana | EUR | - | HLTW IM HLTWEUIV | LHLTW.MI HLTWEURINAV=SOLA | Lang & Schwarz Société Générale |
| Euronext Paris | EUR | HLTW | HLTW FP HLTWEUIV | LYXHLTW.PA HLTWEURINAV=SOLA | Lang & Schwarz Société Générale |
| XETRA | EUR | LYPE | LYPE GY HLTWEUIV | LYPE.DE HLTWEURINAV=SOLA | Lang & Schwarz Société Générale |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| Xtrackers MSCI World Health Care UCITS ETF 1C | 3,543 | 0.25% p.a. | Accumulating | Full replication |
| State Street SPDR MSCI World Health Care UCITS ETF USD | 615 | 0.30% p.a. | Accumulating | Full replication |
| Amundi MSCI World Health Care UCITS ETF USD Acc | 90 | 0.30% p.a. | Accumulating | Swap-based |